821765

Arifulla Khan MD — FEI 3003114854

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 10, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bellevue, WA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
738821 CFR 50.25(a)(2)Reasonably foreseeable risks or discomforts
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance